http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6075057-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3c9fc3cb0028234aedb8df651f9d2e4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C39-23 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C39-23 |
| filingDate | 1997-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2000-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0ae2601d06d4b52f2834212e60e79b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3ed516b241304256cda04160d8b5690 |
| publicationDate | 2000-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6075057-A |
| titleOfInvention | Inhibition of carbohydrates metabolism by quinone compounds |
| abstract | Optically pure enantiomers of avarol are obtained. The enantiomers of avarol are demonstrated to be highly effective inhibitors of alpha -glucosidase and alpha -mannosidase. Other enzymes assayed were not inhibited by these optically pure compounds. Inhibition of these two enzymes is useful for a variety of assays and probes, and offers particular utility in the treatment of retroviral infection-associated syndromes, such as AIDS. |
| priorityDate | 1996-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 184.